1. Obituary

   • Hans-Jochem Kolb

   Obituary 21 August 2010 Pages: 1071 - 1071

2. Rituximab is an effective and safe therapeutic alternative in adults with refractory and severe autoimmune hemolytic anemia

   • Francisco Javier Peñalver
   • Alberto Alvarez-Larrán
   • on behalf of the Multi-institutional Retrospective Study on the use of rituximab in refractory AIHA

   Original Article 05 June 2010 Pages: 1073 - 1080

   

3. Efficacy of MK-0457 and in combination with vorinostat against Philadelphia chromosome positive acute lymphoblastic leukemia cells

   • Seiichi Okabe
   • Tetsuzo Tauchi
   • Kazuma Ohyashiki

   Original Article 20 June 2010 Pages: 1081 - 1087

   

4. Inactivation of PI3k/Akt signaling pathway and activation of caspase-3 are involved in tanshinone I-induced apoptosis in myeloid leukemia cells in vitro

   • Jia-Jun Liu
   • Wen-Da Liu
   • Ren-Wei Huang

   Original Article 30 May 2010 Pages: 1089 - 1097

   

5. Standard-dose imatinib plus low-dose homoharringtonine and granulocyte colony-stimulating factor is an effective induction therapy for patients with chronic myeloid leukemia in myeloid blast crisis who have failed prior single-agent therapy with imatinib

   • Baijun Fang
   • Ning Li
   • Robert Chunhua Zhao

   Original Article 25 May 2010 Pages: 1099 - 1105

6. A systematic review and meta-analysis of rituximab-based immunochemotherapy for subtypes of diffuse large B cell lymphoma

   • Cheng Fang
   • Wei Xu
   • Jian-Yong Li

   Original Article 25 May 2010 Pages: 1107 - 1113

   

7. Simvastatin and purine analogs have a synergic effect on apoptosis of chronic lymphocytic leukemia cells

   • Monika Podhorecka
   • Dorota Halicka
   • Anna Dmoszynska

   Original Article Open access 25 May 2010 Pages: 1115 - 1124

   

8. Antiapoptotic effect of interleukin-2 (IL-2) in B-CLL cells with low and high affinity IL-2 receptors

   • Thomas Decker
   • Christian Bogner
   • Ingo Ringshausen

   Original Article 11 June 2010 Pages: 1125 - 1132

   

9. Polymorphisms in the multiple drug resistance protein 1 and in P-glycoprotein 1 are associated with time to event outcomes in patients with advanced multiple myeloma treated with bortezomib and pegylated liposomal doxorubicin

   • Gabriele Buda
   • Deborah Ricci
   • Robert Z. Orlowski

   Original Article Open access 08 June 2010 Pages: 1133 - 1140

   

10. Allogeneic transplant outcomes are not affected by body mass index (BMI) in patients with haematological malignancies

    • Emmanouil Nikolousis
    • Sandeep Nagra
    • Donald Milligan

    Original Article 11 June 2010 Pages: 1141 - 1145

    

11. Study of 18 functional hemostatic polymorphisms in mucocutaneous bleeding disorders

    • Ana I. Antón
    • Rocio González-Conejero
    • Diego Mezzano

    Original Article 09 June 2010 Pages: 1147 - 1154

12. Evaluation of coagulation kinetics using thromboelastometry—methodologic influence of activator and test medium

    • Benny Sørensen
    • Christian Fenger-Eriksen
    • Jørgen Ingerslev

    Original Article 18 May 2010 Pages: 1155 - 1161

    

13. Outcome of attempted Hickman catheter salvage in febrile neutropenic cancer patients with Staphylococcus aureus bacteremia

    • Ki-Ho Park
    • Oh-Hyun Cho
    • Sung-Han Kim

    Original Article 24 June 2010 Pages: 1163 - 1169

    

14. Hematologic malignancy as a risk factor for bacteremic skin and soft tissue infection caused by gram-negative bacilli

    • Cheol-In Kang
    • Doo Ryeon Chung
    • Korean Network for Study of Infectious Diseases (KONSID)

    Letter to the Editor 24 February 2010 Pages: 1171 - 1173

15. Gastric mucosa-associated lymphoid tissue lymphoma complicated with hemophagocytic syndrome in an elderly woman

    • Hitoshi Ohno
    • Kengo Takimoto

    Letter to the Editor 02 March 2010 Pages: 1175 - 1176

    

16. Combining two orally active iron chelators for thalassemia

    • Vasilios Berdoukas
    • Susan Carson
    • Thomas Coates

    Letter to the Editor 10 March 2010 Pages: 1177 - 1178

17. Oral tranexamic acid as a novel treatment option for persistent haematuria in patients with sickle cell disease

    • Niall F. Davis
    • Barry B. McGuire
    • John M. Fitzpatrick

    Letter to the Editor 01 April 2010 Pages: 1179 - 1180

18. Pancytopenia secondary to hypopituitarism may just be due to hypothyroidism alone

    • Anselm Chi-wai Lee

    Letter to the Editor 23 March 2010 Pages: 1181 - 1181

19. Extramedullary manifestations of multiple myeloma in the thyroid gland and in the lungs: excellent response to therapy

    • Fabia Weisser
    • Christiane Reuter
    • Christian Taverna

    Letter to the Editor Open access 10 April 2010 Pages: 1183 - 1184